Friday, September 17, 2021
wellness India Expo
Home Tags DCGI

Tag: DCGI

AIMED welcomes govt’s advisory on domestic standards for procuring medical devices

The association of Indian medical devices industry has stated that the move will create fair parity between domestically......

Industry welcomes CDSCO’s circular on investigators & sites

The Central Drugs Standard Control Organization's decision reflects the views of most of the stakeholders, mentioned the Indian Society for.......

Quintiles welcomes DCGI’s revised rules on clinical trials

In a statement, one of the leading global players in clinical research has appreciated the move by the Drugs Controller General.....

DCGI revises its 50 bed hospital, 3 clinical trials per investigator...

The Drug Controller General of India has finally decided to revise the earlier move that made maximum 3 trials per investigator....

Biocon registers strong performance, profits up by 17%

Biocon in the first quarter of the financial year 2016-17, has reported the revenues of Rs 952 crore; net profit up by 17 percent at Rs 147 crore ....

Revised ‘India specific’ biosimilar guidelines expected soon

While the 'Biosimilar Guidelines' adopted in 2012 have been well appreciated, there was an overall sentiment ...

Will try to ensure new therapeutics reach patients at earliest, says...

Dr G N Singh, Drug Controller General of India (DCGI) has sought cooperation from all the stakeholders...

HSI calls for adoption of animal-free ‘Tox21’ testing model for skin...

Humane Society International, India has urged the regulatory authorities, including the DCGI....

ISCR hails DCGI’s notification on academic research trials, says will boost...

The recent amendment will significantly reduce start-up timelines due to exemption from the...

Special: Bioscience sector expects big ticket budget

The union budget 2016-17 is being eagerly awaited to unfold few major announcements favoring expansion....